Dr Joshua Inglis
School of Medicine
College of Health
I am a dedicated health leader committed to enhancing the patient experience and optimising the delivery of healthcare. With a diverse background spanning clinical practice, digital health systems and academia, I bring a unique blend of skills to drive positive change.
I am a Consultant Physician in General Medicine and Clinical Pharmacology working across hospital medicine, digital health and medication safety. As a Senior Clinical Lecturer and active researcher, I am currently completing my PhD on health outcomes for older adults with multimorbidity.
I have been an expert reviewer for Human Research Ethics Committees in both the public and private settings specialising in clinical trials. I also have been a consultant for health technology assessment groups working at the state and national level, bringing my expertise in translational pharmacology, clinical trials and health outcomes research to these roles.
| Date | Position | Institution name |
|---|---|---|
| 2026 - ongoing | Consultant Physician - General Medicine | Central Adelaide Local Health Network |
| 2025 - ongoing | Senior Clinical Lecturer | Adelaide University |
| 2024 - ongoing | Consultant Physician - Clinical Pharmacology | South Adelaide Local Health Network |
| 2024 - ongoing | Clinicial Informatician | Department of Health and Wellbeing |
| 2019 - 2025 | Associate Clinical Lecturer | University of Adelaide |
| Date | Institution name | Country | Title |
|---|---|---|---|
| 2016 - 2016 | Flinders University | Australia | Graduate Certificate in Clinical Education |
| 2011 - 2016 | University of Adelaide | Australia | Bachelor of Medicine and Bachelor of Surgery |
| Date | Title | Institution | Country |
|---|---|---|---|
| 2023 | Fellowship of the Adult Medicine Division | Royal Australasian College of Physicians | Australia |
| 2021 - 2022 | Clinical Diploma in Palliative Medicine | Royal Australasian College of Physicians | Australia |
| Year | Citation |
|---|---|
| 2026 | Inglis, J. M., Caughey, G. E., Liew, D., & Shakib, S. (2026). Prevalence of multimorbidity and uptake of guideline-directed medicines for cardiovascular conditions in Australian hospitalised adults: a cross-sectional study. BMJ Open, 16(2), e103243-1-e103243-10. |
| 2026 | Jiang, M., Lam, L., Kovoor, J., Inglis, J. M., Shakib, S., Yuson, C., . . . Smith, W. (2026). Drug Reaction with Eosinophilia and Systemic Symptoms in the Electronic Medical Record.. Int Arch Allergy Immunol, 1-10. |
| 2025 | Tan, J. Y., Ephraums, L. A., Inglis, J. M., Nguyen, H. T. T., Umapathysivam, M. M., Simpson, N. J., . . . Thynne, T. R. J. (2025). A Cross-Sectional Study of Capillary Blood Ketone Concentrations in Heart Failure Based on Sodium-Glucose Co-Transporter-2 Inhibitor Use and Heart Failure Type. Heart Lung and Circulation, 34(1), 34-39. Scopus2 WoS2 Europe PMC2 |
| 2025 | Hurley, S. P., Horwood, C., Mallon, J., Mangoni, A. A., & Inglis, J. M. (2025). Characteristics of paracetamol poisoning in a local health network and consistency of hospital management with national guidelines. Internal Medicine Journal, 55(1), 139-142. |
| 2025 | Jiang, M., Stretton, B., Kovoor, J., Inglis, J. M., Thompkins, S., Yuson, C., . . . Bacchi, S. (2025). Proactive deep learning-facilitated inpatient penicillin allergy delabelling: An implementation study.. International archives of allergy and immunology, 186(8), 1-15. |
| 2025 | Inglis, J. M., & Mangoni, A. A. (2025). Mirtazapine for chronic insomnia in older adults: weighing the risks and potential benefits. Age and Ageing, 54(4), 3 pages. Scopus1 WoS1 |
| 2025 | Amer, H., Marotti, S., Inglis, J. M., Widagdo, I., Goldsworthy, S., Johnson, J., & Kalisch Ellett, L. (2025). Evaluating medication discrepancies and harm: a matched cohort study of collaborative pharmacist prescribing in a statewide healthcare system using electronic prescribing. International Journal of Clinical Pharmacy, online(1), 1-10. Scopus1 WoS1 Europe PMC1 |
| 2024 | Vitry, A., Inglis, J., & Caird, C. (2024). Evidence of clinical benefit of cancer medicines considered for funding in Australia. International Journal of Technology Assessment in Health Care, 40(1, article no. e55), 1-7. Scopus1 WoS1 |
| 2024 | Lee, W. I., Lam, L., Bacchi, S., Jiang, M., Inglis, J. M., Smith, W., & Hissaria, P. (2024). Antibiotic prophylaxis in immunosuppressed patients – Missed opportunities from trimethoprim-sulfamethoxazole allergy label. World Allergy Organization Journal, 17(1), 14 pages. Scopus9 WoS8 Europe PMC5 |
| 2024 | Al Naji, H., Inglis, J. M., Tucker, E., Rowett, D., Larcombe, R., Medlin, S., . . . Thynne, T. (2024). Prescribing of antivirals for COVID-19 in a South Australian local health network according to statewide guidelines. Internal Medicine Journal, 54(1), 183-186. Scopus2 WoS3 Europe PMC1 |
| 2024 | Stanekova, V., Inglis, J. M., Lam, L., Lam, A., Smith, W., Shakib, S., & Bacchi, S. (2024). Improving the performance of machine learning penicillin adverse drug reaction classification with synthetic data and transfer learning.. Internal Medicine Journal, 54(7), 1183-1189. Scopus6 WoS6 Europe PMC2 |
| 2024 | Umapathysivam, M. M., Morgan, B., Inglis, J. M., Meyer, E., Liew, D., Thiruvenkatarajan, V., & Jesudason, D. (2024). SGLT2 Inhibitor-Associated Ketoacidosis vs Type 1 Diabetes-Associated Ketoacidosis. JAMA Network Open, 7(3), E242744. Scopus15 WoS16 Europe PMC11 |
| 2024 | Inglis, J. M., Caughey, G., Thynne, T., Brotherton, K., Liew, D., Mangoni, A. A., & Shakib, S. (2024). Association of Drug–Disease Interactions with Mortality or Readmission in Hospitalised Middle-Aged and Older Adults: A Systematic Review and Meta-Analysis. Drugs Real World Outcomes, 11(3), 345-360. Scopus5 WoS5 Europe PMC3 |
| 2024 | Inglis, J. M., Medlin, S., Bryant, K., Mangoni, A. A., & Phillips, C. J. (2024). The Clinical Impact of Hospital-Acquired Adverse Drug Reactions in Older Adults: An Australian Cohort Study. Journal of the American Medical Directors Association, 25(8, article no. 105083), 1-9. Scopus2 WoS1 Europe PMC2 |
| 2024 | Inglis, J. M., Caughey, G., Thynne, T., Brotherton, K., Liew, D., Mangoni, A. A., & Shakib, S. (2024). Inappropriate prescribing and association with readmission or mortality in hospitalised older adults with frailty: a systematic review and meta-analysis.. BMC Geriatrics, 24(1), 18 pages. Scopus2 WoS2 Europe PMC2 |
| 2023 | Umapathysivam, M. M., Inglis, J. M., Morgan, B., Meyer, E., Thiruvenkatarajan, V., & Jesudason, D. (2023). Letter to the Editor: Response to Hamblin et al body mass index is inversely associated with capillary ketones at the time of colonoscopy: Implications for SGLT2i use. Clinical Endocrinology, 98(3), 449-451. Scopus3 WoS3 Europe PMC1 |
| 2023 | Jiang, M., Bacchi, S., Lam, L., Inglis, J. M., Gluck, S., Smith, W., & Gilbert, T. (2023). Antibiotic Prescribing Practices Differ between Patients with Penicillin Intolerance and Penicillin Allergy Labels. International Archives of Allergy and Immunology, 184(2), 1-5. Scopus13 WoS12 Europe PMC6 |
| 2023 | Thiruvenkatarajan, V., Inglis, J. M., Meyer, E., Umapathysivam, M. M., Nanjappa, N., Van Wijk, R., & Jesudason, D. (2023). Peri-colonoscopy Implications of Sodium-Glucose Cotransporter-2 Inhibitor Therapy: A Mini-review of Available Evidence. Canadian Journal of Diabetes, 47(3), 287-291. Scopus3 WoS3 Europe PMC3 |
| 2023 | Jiang, M., Lam, A., Lam, L., Kovoor, J., Inglis, J., Shakib, S., . . . Bacchi, S. (2023). Artificial intelligence and the potential for perioperative delabeling of penicillin allergies for neurosurgery inpatients.. Br J Neurosurg, 39(1), 1-4. Scopus4 WoS6 Europe PMC5 |
| 2023 | Inglis, J. M., Yuson, C., & Smith, W. (2023). Recording and communicating opioid adverse drug reactions is an important element of opioid stewardship. Internal Medicine Journal, 53(3), 454. Scopus1 Europe PMC1 |
| 2023 | Jiang, M., Bacchi, S., Lam, L., Lam, A., Inglis, J. M., Gilbert, T., . . . Smith, W. (2023). Low-risk cefalexin allergies are associated with inpatient prescribing of second-line non-beta-lactam antibiotics. Allergo Journal International, 33(3), 73-79. Scopus2 |
| 2023 | Inglis, J. M., Kichenadasse, G., & Mangoni, A. A. (2023). Current and emerging medications for the management of obesity in adults. Medical Journal of Australia, 219(4), 187. Scopus1 WoS1 |
| 2023 | Inglis, J. M., Bacchi, S., Troelnikov, A., Smith, W., & Shakib, S. (2023). Machine learning models automate classification of penicillin adverse drug reaction labels.. Intern Med J, 53(8), 1485-1488. Scopus3 WoS2 Europe PMC1 |
| 2023 | Lam, L., Jiang, M., Bacchi, S., Kovoor, J., Inglis, J. M., Shakib, S., . . . Smith, W. (2023). Prevalence of Trimethoprim-Sulfamethoxazole Adverse Reaction Mislabelling in Australia.. International archives of allergy and immunology, 184(12), 1-5. Scopus3 WoS2 Europe PMC3 |
| 2023 | Inglis, J. M., & Mangoni, A. A. (2023). Protecting the heart. Elife, 12, 3 pages. |
| 2023 | Koopowitz, S. M., Arnold, M., Inglis, J. M., Hon, K., Vanlint, A., Koopowitz, L. F., & O’Callaghan, G. (2023). A community of practice to address system-based issues and promote clinical leadership among trainee medical officers in a large public health service: an evaluation of a trainee-led forum. Australian Health Review, 47(6), 667-670. |
| 2023 | Stretton, B., Jiang, M., Kovoor, J., Inglis, J. M., Lam, L., Tan, S., . . . Bacchi, S. (2023). Artificial intelligence-enabled penicillin allergy delabelling: an implementation study.. Internal medicine journal, 53(11), 2119-2122. Scopus7 WoS9 Europe PMC6 |
| 2022 | Inglis, J. M., Furst, C., & Foreman, L. (2022). Noninvasive respiratory supports for the relief of terminal breathlessness. Current Opinion in Supportive and Palliative Care, 16(2), 78-82. Scopus3 WoS3 Europe PMC2 |
| 2021 | Lambrecht, A., Inglis, J. M., & Young, R. (2021). Abdominal pain with intra-adrenal bleeding as an initial presentation of pheochromocytoma. BMJ Case Reports, 14(1), 4 pages. Scopus1 WoS1 Europe PMC2 |
| 2021 | Inglis, J. M., Caughey, G. E., Smith, W., & Shakib, S. (2021). Documentation of Adverse Drug Reactions to Opioids in an Electronic Health Record.. Intern Med J, 51(9), 1490-1496. Scopus9 WoS9 Europe PMC9 |
| 2021 | Inglis, J. M., Bacchi, S., Troelnikov, A., Smith, W., & Shakib, S. (2021). Automation of penicillin adverse drug reaction categorisation and risk stratification with machine learning natural language processing. International Journal of Medical Informatics, 156, 104611-1-104611-5. Scopus28 WoS26 Europe PMC18 |
| 2020 | Foreman, C., Le, T. T. A., Inglis, J. M., & Smith, W. B. (2020). Penicillin allergy labeling on medical alert jewelry. Annals of Allergy Asthma and Immunology, 124(6), 627-629. Scopus1 WoS1 Europe PMC1 |
| 2020 | Inglis, J. M., & Tan, J. (2020). Scurvy presenting as lower limb ecchymoses in the setting of metastatic colorectal cancer. BMJ Case Reports, 13(12), 4 pages. Scopus2 WoS2 Europe PMC1 |
| 2019 | Inglis, J. M., Caughey, G. E., & Shakib, S. (2019). Use of non-formulary high-cost medicines in an Australian public hospital. International Journal of Clinical Pharmacy, 41(4), 920-931. Scopus6 WoS6 Europe PMC5 |
| 2019 | Caughey, G. E., Shakib, S., Inglis, J. M., Le, T. T., Yuson, C. L., & Smith, W. B. (2019). External validation of beta-lactam antibiotic allergy assessment tools: implications for clinical practice and workforce capacity. Journal of allergy and clinical immunology: In Practice, 7(6), 2094-2095. Scopus5 WoS5 Europe PMC3 |
| 2018 | Inglis, J. M., Barbara, J. A., Juneja, R., Milton, C., Passaris, G., & Li, J. Y. Z. (2018). Atypical Haemolytic Uraemic Syndrome Associated with <i>Clostridium difficile</i> Infection Successfully Treated with Eculizumab.. Case reports in nephrology, 2018, 1759138. Europe PMC5 |
| 2018 | Inglis, J. M., & Wood, N. K. (2018). Breaking the routine of peripheral venous catheter replacement. Internal Medicine Journal, 48(5), 606. Scopus1 Europe PMC1 |
| 2017 | Inglis, J., Caughey, G., Smith, W., & Shakib, S. (2017). Documentation of penicillin adverse drug reactions in electronic health records: inconsistent use of allergy and intolerance labels. Internal Medicine Journal, 47(11), 1292-1297. Scopus82 WoS79 Europe PMC62 |
| 2016 | Kremer, K., Smith, A., Sandeman, L., Inglis, J., Ridding, M., & Koblar, S. (2016). Transcranial magnetic stimulation of human adult stem cells in the mammalian brain. Frontiers in Neural Circuits, 10(MAR), 17-1-17-9. Scopus10 WoS9 Europe PMC7 |
| - | Inglis, J. M., Caughey, G. E., Air, T., Maddison, J., Liew, D., & Shakib, S. (2026). Predictors of Non-Cardiovascular Readmissions in Multimorbid Adults with Heart Failure in Australian Hospitals: A Retrospective Cohort Study. Journal of Clinical Medicine, 15(13), 5275. |
| Date | Role | Committee | Institution | Country |
|---|---|---|---|---|
| 2023 - ongoing | Member | South Australian Medicines Evaluation Panel | Department of Health and Wellbeing | Australia |
| 2023 - ongoing | Member | HREC Reviewer | Bellberry | Australia |
| Date | Institution | Department | Organisation Type | Country |
|---|---|---|---|---|
| 2023 - ongoing | Adelaide University | Adelaide Health Technology Assessment Group | School or college | Australia |
| 2022 - ongoing | Australian Medicines Handbook | - | Health services and related | Australia |
Connect With Me
External Profiles
